IPAR at a glance
INTERPARFUMS INC (IPAR, SEC CIK 822663) filed its latest 10-K annual report on March 10, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 18, 2026 and Form 4 insider filings as recently as August 27, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), INTERPARFUMS INC (IPAR) reported revenue of $1.5 billion (up 2.5% from FY2024) and net income of $168.4 million. Diluted EPS was $5.24.
- As of September 30, 2026, 33 institutional investment managers tracked by SignalX reported holding INTERPARFUMS INC (IPAR) shares worth $1.3 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Gabai-Pinsky Veronique on August 27, 2026 of 900 shares at $116.86 per share.
- In the last 90 days, IPAR insiders reported 0 open-market purchases ($0) and 1 open-market sale ($105K) on Form 4, a net sale of $105K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $1.5B
- +2.5% vs prior year
- Insiders · 90 days
- 0 buys · 1 sell
- Net −$105K
- 13F holders
- 33 funds
- $1.3B · −1 vs prior quarter
- Latest 8-K
- Nov 18, 2026
- Item 7.01
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Core business model centered on fragrance creation, manufacturing, and distribution globally
- Emphasis on strengthened cybersecurity operations with dedicated IT departments in U.S. and Europe managing network security and incident prevention
- New IT Charter and mandatory cybersecurity training initiated January 2024 for all Interparfums SA employees
- No material cybersecurity incidents reported as of filing date, indicating effective risk mitigation
- Implementation of daily data backups, two-factor authentication, and quarterly password updates across workforce
Management Discussion & Analysis
- Foreign currency forward contracts $64M notional, mature within one year, used to hedge receivables and forecasted sales
- Derivatives recorded at fair value, gains/losses recognized in earnings or other comprehensive income if cash flow hedge
- Hedge effectiveness measured continuously, any ineffectiveness recognized in income statement
- No trading in foreign currency forwards or interest rate swaps; risk of counterparty nonperformance considered remote
- Interest rate risk managed by monitoring rates and swapping fixed/floating debt as needed
AI summary of the IPAR 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Management Discussion & Analysis
- Q3 revenue $429.5M, down $0.1M YoY, with European sales $305.9M and U.S. sales $127.3M
- Operating margin 27.4% vs 25.3% YoY, gross margin 67.1% vs 63.5%
- Best segment Europe: sales up 4%; Coach sales up 23%, while weakest U.S. sales declined 7%
- Cash, equivalents and short-term investments $240.2M; operating cash flow $102.3M vs $68.4M
- Outlook positive for holiday season and 2027, with Middle East conflict, tariffs and supply-chain disruptions as headwinds
Risk Factors
- No material changes to risk factors reported from the 2025 Form 10-K
- Significant carried-forward risks remain those disclosed in the 2025 Annual Report, without quarterly updates
AI summary of the IPAR 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 7.01: Regulation FD Disclosure
- Initial 2027 guidance announced in November 18, 2026 press release
- Guidance factors outlined in Exhibit 99.1, relevant to forward earnings expectations
Item EX-99.1: Item EX-99.1
- 2027 guidance: net sales $1.58B, up 6% versus estimated 2026 sales of $1.49B
- Diluted EPS guidance $5.00, up 3% reported, or approximately 11% excluding the $0.35 tariff-refund benefit
Item 2.02: Results of Operations and Financial Condition
- Third-quarter and nine-month results ended September 30, 2026, announced in November 4 press release
- Sales by territory for the first nine months, with detailed unaudited financial statements in Exhibit 99.1
Item 7.01: Regulation FD Disclosure
- Press release provides 2026-2028 outlook, giving investors a multi-year framework for growth expectations
- 2026 guidance increased, signaling stronger anticipated operating performance
Item EX-99.1: Item EX-99.1
- Q3 sales $430M, flat YoY, but gross margin expanded to 67.1% from 63.5%, driving EPS growth to $2.13 from $2.05
- Nine-month sales $1.115B, up 1%, with EPS $4.43, up 2%, despite regional weakness in Eastern Europe and the Middle East
Item EX-99.1: Item EX-99.1
- Q3 net sales flat at $430 million; nine-month sales up 1% to $1,115 million
- European operations grew 4% to $306 million, offsetting U.S. operations down 7% to $127 million
Item 2.02: Results of Operations and Financial Condition
- Exhibit 99.1 reports Interparfums net sales for Q3 and the nine months ended September 30, 2026
- Filing incorporates selected press-release paragraphs, directing investors to Exhibit 99.1 for sales details and management commentary
Item 7.01: Regulation FD Disclosure
- Management reaffirmed a positive 2027 outlook, supported by global brands, market strength, partnerships and licensing opportunities
- 2027 growth initiatives include Lacoste marketing innovations, new launches and anticipated blockbuster products
AI summaries of IPAR 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for IPAR
Don't miss the next IPAR filing
- Alerts as it files. A push when IPAR files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut IPAR, by share count.
- Ask anything. An AI agent that reads every IPAR filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Gabai-Pinsky Veronique | M | Aug 27, 2026 | 300 | - |
| Gabai-Pinsky Veronique | M | Aug 27, 2026 | 300 | - |
| Gabai-Pinsky Veronique | M | Aug 27, 2026 | 300 | - |
| Gabai-Pinsky Veronique | M | Aug 27, 2026 | 900 | $97.84 |
| Gabai-Pinsky Veronique | Sell | Aug 27, 2026 | 900 | $116.86 |
| HEILBRONN FRANCOIS | M | Jan 23, 2026 | 375 | - |
| HEILBRONN FRANCOIS | M | Jan 23, 2026 | 375 | - |
| HEILBRONN FRANCOIS | M | Jan 23, 2026 | 1,500 | $62.18 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $1.5B | $1.5B |
| Gross Profit | - | $927.3M | $947.2M |
| Operating Income | - | $274.8M | $270.3M |
| Net Income | - | $164.4M | $168.4M |
| Gross Margin | - | 63.9% | 63.6% |
| Op. Margin | - | 18.9% | 18.2% |
| Net Margin | - | 11.3% | 11.3% |
| Balance Sheet | |||
| Total Assets | $1.4B | $1.4B | $1.6B |
| Equity | $699.4M | $744.9M | $880.7M |
| ROE | - | 22.1% | 19.1% |
| Per Share | |||
| EPS | - | $5.12 | $5.24 |
| Cash Flow | |||
| Operating CF | - | $187.6M | $214.9M |
| CapEx | - | $4.7M | $24.4M |
Source: XBRL data in INTERPARFUMS INC (IPAR)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate IPAR share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 33 | $1.27B |
| Q2 2026 | 34 | $1.34B |
| Q1 2026 | 34 | $1.04B |
| Q4 2025 | 32 | $970.7M |
| Q3 2025 | 33 | $1.13B |
| Q2 2025 | 31 | $1.37B |
| Q1 2025 | 28 | $798.1M |
| Q4 2024 | 26 | $754.9M |
- Morgan Stanley+95.8K (+7%)
- Citadel Advisors LLC+57.6K (+1415%)
- Citigroup+41.2K (+214%)
- Bank of America Corp+12.8K (+5%)
- Invesco Ltd+8.1K (+2%)
- WESTWOOD HOLDINGS GROUP INC−271.0K (-31%)
- Goldman Sachs Group−82.1K (-26%)
- Vanguard Portfolio Management LLC−73.1K (-6%)
- BlackRock−71.0K (-2%)
- JPMorgan Chase & Co−52.0K (-37%)
- FMR LLC (Fidelity)−10.2K
Source: 13F-HR filings on SEC EDGAR (aggregated from 251 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
IPAR filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Nov 18, 2026 | - | Analysis | - |
| 8-K | Nov 4, 2026 | - | Analysis | - |
| 10-Q | Nov 4, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Oct 20, 2026 | - | Analysis | - |
| 8-K | Sep 22, 2026 | - | Analysis | - |
| 8-K | Sep 17, 2026 | - | Analysis | - |
| 8-K | Sep 16, 2026 | - | Analysis | - |
| 4 | Aug 27, 2026 | - | - | - |
| 8-K | Aug 4, 2026 | - | Analysis | - |
| 10-Q | Aug 4, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Jul 22, 2026 | - | Analysis | - |
| 8-K | May 13, 2026 | - | Analysis | |
| 10-Q | May 5, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | May 5, 2026 | - | Analysis | - |
| 8-K | Apr 21, 2026 | - | Analysis | - |
| 10-K | Mar 10, 2026 | Dec 31, 2025 | Analysis | |
| 8-K | Feb 24, 2026 | - | Analysis | - |
| 8-K | Jan 29, 2026 | - | - | |
| 8-K | Jan 29, 2026 | - | - | |
| 4 | Jan 26, 2026 | - | - | |
| 8-K | Jan 26, 2026 | - | - | |
| 4 | Jan 23, 2026 | - | - | |
| 4 | Jan 23, 2026 | - | - | |
| 8-K | Jan 21, 2026 | - | - | |
| 4 | Jan 5, 2026 | - | - |
Related Consumer Staples companies
- CL · Colgate-PalmolivePerfumes, Cosmetics & Other Toilet Preparations
- EPC · EDGEWELL PERSONAL CARE CoPerfumes, Cosmetics & Other Toilet Preparations
- EL · Estée Lauder Companies (The)Perfumes, Cosmetics & Other Toilet Preparations
- KVUE · KenvuePerfumes, Cosmetics & Other Toilet Preparations
- OLPX · OLAPLEX HOLDINGS, INC.Perfumes, Cosmetics & Other Toilet Preparations
- SLSN · SOLESENCE, INC.Perfumes, Cosmetics & Other Toilet Preparations
- WALD · Waldencast plcPerfumes, Cosmetics & Other Toilet Preparations
- ACI · Albertsons Companies IncRetail-Grocery Stores
IPAR SEC filings: frequently asked questions
Are IPAR insiders buying or selling?
In the last 90 days, INTERPARFUMS INC (IPAR) officers, directors and 10% owners reported no open-market purchases and 1 open-market sale worth $105,173 by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold IPAR stock?
As of September 30, 2026, the largest INTERPARFUMS INC (IPAR) holders among the 13F filers tracked by SignalX were BlackRock ($315.8 million), Morgan Stanley ($158.4 million), Vanguard Portfolio Management LLC ($136.8 million), Dimensional Fund Advisors ($95.6 million), Vanguard Capital Management LLC ($88.6 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was IPAR's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), INTERPARFUMS INC (IPAR) reported revenue of $1.5 billion (up 2.5% from FY2024) and net income of $168.4 million. Diluted EPS was $5.24. The figures come from the XBRL data in the 10-K.
What did IPAR report in its latest 8-K?
INTERPARFUMS INC (IPAR) filed an 8-K on November 18, 2026 reporting Item 7.01 (Regulation FD Disclosure). Initial 2027 guidance announced in November 18, 2026 press release.
What are the latest IPAR SEC filings?
INTERPARFUMS INC (IPAR) filed its latest 10-K annual report on March 10, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 18, 2026 and a Form 4 insider filing on August 27, 2026.
What is IPAR's SEC CIK number?
INTERPARFUMS INC (IPAR)'s SEC Central Index Key (CIK) is 822663. EDGAR lists every IPAR filing under that number.
Ask anything about IPAR
The research agent reads IPAR's filings, financials, insider trades and 13F holders, then answers with sources.